Search

Search Constraints

You searched for: Author/Creator Terzi, Murat

Search Results

1. 004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis. (23rd August 2021)

2. Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS. (5th September 2017)

3. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study. (14th June 2022)

4. Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis. (October 2018)

5. Comparative effectiveness in multiple sclerosis: A methodological comparison. (March 2023)

6. Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry. (February 2023)

7. Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS. Issue 2 (April 2016)

8. Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis. Issue 4 (13th January 2019)

9. Confirmed disability progression as a marker of permanent disability in multiple sclerosis. (9th June 2022)

10. Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180]. (January 2022)